Latest news with #Tendonitis
BBC News
26-06-2025
- Health
- BBC News
Dr Tom Naylor's tips for Tendonitis
Here's everything you need to know about managing your Tendonitis:Tendonitis is when a tendon swells (becomes inflamed) after an injury. It can cause joint pain and stiffness, and affect how a tendon may hear medical professionals refer to tendon issues as 'Tendinopathy', and that includes the early painful inflammatory stages known as Tendonitis, but also the later, niggling, annoying pains that are more difficult to are four places where we see it most often: the Elbow, Achilles, knees, and elbow - excessive strain and repetition in wrist extensor tendons, causes irritating and often quite debilitating pain around the lateral side of the elbow (think a "back-hand" movement).Golfer's elbow - the same, but on the opposite side of the elbow, from strain in wrist flexor tendonsAchilles tendonitis - from pushing off and lunging. Very common movement in padel, also common to get from runningPatellar tendonitis - from squatting, jumping and lunging external is a link to some more information on treating Tendonitis. Here, external is a link to some stretches to help manage Achilles Tendinopathy. Here, external is a link to some stretches to help with Tennis Elbow.
Globe and Mail
04-04-2025
- Business
- Globe and Mail
TRB Chemedica, CollPlant, Novartis, Orthocell, MiMedX group, InGeneron, R3 Stem Cell
The Key Tendonitis Companies in the market include - TRB Chemedica, CollPlant, Novartis, Orthocell, MiMedX group, InGeneron, Novartis, R3 Stem Cell, Orthocell, and others. The Tendonitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Tendonitis pipeline products will significantly revolutionize the Tendonitis market dynamics. DelveInsight's 'Tendonitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Tendonitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. To Know in detail about the Tendonitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Tendonitis Market Insights Some of the key facts of the Tendonitis Market Report: The Tendonitis market size is anticipated to grow with a significant CAGR during the study period (2020-2034) In the 7MM, the United States held the largest market share for tendonitis, valued at approximately USD 2,500 million in 2023. In the 7MM, the United States recorded the highest number of tendonitis incident cases, exceeding 4 million in 2023. Key Tendonitis Companies: TRB Chemedica, CollPlant, Novartis, Orthocell, MiMedX group, InGeneron, Novartis, R3 Stem Cell, Orthocell, and others Key Tendonitis Therapies: OSTENIL TENDON, VergenixSTR, Cosentyx (Secukinumab/AIN457), Tendon Cell Therapy, AmnioFix, Adipose-derived regenerative cells (ADRC), Secukinumab, Amniotic stem cells, Ortho-ATI, and others Get a Free sample for the Tendonitis Market Report: Tendonitis Overview Tendonitis is an inflammation of a tendon – a thick, flexible cord of tissue that attaches muscles to bone and assists in moving the bone or structure. Tendonitis most commonly occurs in the shoulder, bicep, elbow, hand, wrist, thumb, calf, knee, or ankle. Since the pain of tendonitis occurs near a joint, it is sometimes mistaken for arthritis. The condition is more common in adults over the age of 40 and athletes. Some forms of tendonitis are named after certain sports (e.g., tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, and jumper's knee). Tendonitis Epidemiology The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends. Tendonitis Epidemiology Segmentation: The Tendonitis market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into: Total Prevalence of Tendonitis Prevalent Cases of Tendonitis by severity Gender-specific Prevalence of Tendonitis Diagnosed Cases of Episodic and Chronic Tendonitis Download the report to understand which factors are driving Tendonitis epidemiology trends @ Tendonitis Epidemiological Insights Tendonitis Drugs Uptake and Pipeline Development Activities The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Tendonitis market or expected to get launched during the study period. The analysis covers Tendonitis market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share. The report also covers the Tendonitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies. Tendonitis Therapies and Key Companies OSTENIL TENDON: TRB Chemedica VergenixSTR: CollPlant Cosentyx (Secukinumab/AIN457): Novartis Tendon Cell Therapy: Orthocell AmnioFix: MiMedX group Adipose-derived regenerative cells (ADRC): InGeneron Secukinumab: Novartis Amniotic stem cells: R3 Stem Cell Ortho-ATI: Orthocell Discover more about therapies set to grab major Tendonitis market share @ Tendonitis Medications Tendonitis Market Drivers Increase in the targeted patient pool Novel Tendonitis treatment approaches Tendonitis Market Barriers Delayed diagnosis of the disease Limitations associated with the current treatment Scope of the Tendonitis Market Report Study Period: 2020–2034 Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan] Key Tendonitis Companies: TRB Chemedica, CollPlant, Novartis, Orthocell, MiMedX group, InGeneron, Novartis, R3 Stem Cell, Orthocell, and others Key Tendonitis Therapies: OSTENIL TENDON, VergenixSTR, Cosentyx (Secukinumab/AIN457), Tendon Cell Therapy, AmnioFix, Adipose-derived regenerative cells (ADRC), Secukinumab, Amniotic stem cells, Ortho-ATI, and others Tendonitis Therapeutic Assessment: Tendonitis current marketed and Tendonitis emerging therapies Tendonitis Market Dynamics: Tendonitis market drivers and Tendonitis market barriers Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies Tendonitis Unmet Needs, KOL's views, Analyst's views, Tendonitis Market Access and Reimbursement To know more about Tendonitis treatment, visit @ Tendonitis Treatment Landscape Table of Contents 1. Tendonitis Market Report Introduction 2. Executive Summary for Tendonitis 3. SWOT analysis of Tendonitis 4. Tendonitis Patient Share (%) Overview at a Glance 5. Tendonitis Market Overview at a Glance 6. Tendonitis Disease Background and Overview 7. Tendonitis Epidemiology and Patient Population 8. Country-Specific Patient Population of Tendonitis 9. Tendonitis Current Treatment and Medical Practices 10. Tendonitis Unmet Needs 11. Tendonitis Emerging Therapies 12. Tendonitis Market Outlook 13. Country-Wise Tendonitis Market Analysis (2020–2034) 14. Tendonitis Market Access and Reimbursement of Therapies 15. Tendonitis Market Drivers 16. Tendonitis Market Barriers 17. Tendonitis Appendix 18. Tendonitis Report Methodology 19. DelveInsight Capabilities 20. Disclaimer 21. About DelveInsight About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach. Media Contact Company Name:DelveInsight Contact Person: Gaurav Bora Email:Send Email Phone: +14699457679 Address:304 S. Jones Blvd #2432 City: Las Vegas State: Nevada Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Tendonitis Market Growth Projections 2024-2034: DelveInsight Analysis | TRB Chemedica, CollPlant, Novartis, Orthocell, MiMedX group, InGeneron, R3 Stem Cell This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
